CN101979057A - Medicine for treating anaphylactoid purpura and preparation method thereof - Google Patents
Medicine for treating anaphylactoid purpura and preparation method thereof Download PDFInfo
- Publication number
- CN101979057A CN101979057A CN 201010505907 CN201010505907A CN101979057A CN 101979057 A CN101979057 A CN 101979057A CN 201010505907 CN201010505907 CN 201010505907 CN 201010505907 A CN201010505907 A CN 201010505907A CN 101979057 A CN101979057 A CN 101979057A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- parts
- anaphylactoid purpura
- purpura
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating anaphylactoid purpura, which is prepared from weeping forsythiae, Chinese gromwell, the root of red-rooted salvia, the dried rhizome of rehmannia, the root bark of the peony tree, fructus gardeniae preparatus, red paeony root, lalang grass rhizome, yerbadetajo herba ecliptae, peach seed, rheum officinale and pseudo-ginseng. The medicine can be prepared into various clinical formulations, preferably oral liquid. The medicine mainly has the effects of clearing heat and releasing toxin, removing stasis and eliminating spots, and cooling blood to stop bleeding, has good curative effect on diseases such as the anaphylactoid purpura, particularly early blood-heat stasis type purpura, has high effective rate, is safe and reliable for clinical application, and does not have obvious toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of anaphylactoid purpura, specially referring to a kind of is the medicine of the treatment anaphylactoid purpura of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In the modern life, anaphylactoid purpura is a kind of common disease, and anaphylactoid purpura claims Heng-Shu syndrome again, is a kind of more common blood capillary allergy hemorrhage.The cause of disease has the allergy due to infection, food anaphylaxis, drug allergy, pollen, the insect bite etc. etc., but anaphylactogen is determined because of often being difficult to.Child and teenager are more to be seen, the male sees that than the women often there is the upper respiratory tract infection history in preceding 1～3 week of onset more.So should enhance your vigilance to anaphylactoid purpura, treatment as early as possible.
The medicine of western medicine anaphylactoid purpura is more at present.As antihistamine drug commonly used such as diphenhydramine, promethazine, buclizine, chlorphenamine etc. and glucocorticoid etc.These medicine life-time service are all very big to the side effect of human body, and these medicines are mainly used in eliminates surperficial pain symptom, and the recurrence easily of treatment back usually is difficult to radical cure.
The Chinese traditional treatment anaphylactoid purpura is special advantages especially.The primary disease traditional Chinese medical science claims " purpura ", " purpura ", belongs to Chinese medicine blood disorder category, and diseases such as " hemorrhagic disease with purpura " put down in writing in the traditional Chinese medical science ancient books, " hematohidrosis ", " speckle poison " have similarity with primary disease.
Existing this sick Chinese medicine of treatment is often at a kind of specific symptom, and the reason of anaphylactoid purpura is more, does not therefore often influence therapeutic effect because do not suit the medicine to the illness.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine that is applicable to multiple anaphylactoid purpura, and its therapeutic effect is good, and cost is low, and toxic and side effects is less.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by following materials based on weight:
Fructus Forsythiae 10-20 part, Radix Arnebiae (Radix Lithospermi) 7-14 part, Radix Salviae Miltiorrhizae 8-15 part, 12 parts in the Radix Rehmanniae, 10 parts of Cortex Moutans, Fructus Gardeniae Preparatus 7-14 part, Radix Paeoniae Rubra 7-14 part, Rhizoma Imperatae 30-40 part, Herba Ecliptae 15-30 part, Semen Persicae 8-15 part, Radix Et Rhizoma Rhei 6-10 part, Radix Notoginseng 1-3 part.
The further quality proportioning of each component of medicine of the present invention is:
15 parts of Fructus Forsythiaes, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 12 parts of Radix Salviae Miltiorrhizaes, 12 parts in the Radix Rehmanniae, 10 parts of Cortex Moutans, 10 parts of Fructus Gardeniae Preparatuss, 10 parts of Radix Paeoniae Rubra, 35 parts of Rhizoma Imperataes, 22 parts of Herba Ecliptaes, 9 parts in Semen Persicae, 7 parts of Radix Et Rhizoma Rhei, 2 parts of Radix Notoginseng.
The medicine of above-mentioned each component can be made said medicine on any pharmaceutics, and the preferred dosage form of the present invention is an oral liquid.
The concrete preparation method of medicine of the present invention may further comprise the steps:
The raw material of getting above-mentioned mass fraction mixes, and adds the water of 2-4 times of dose, and water decocts after 20-40 minute and extracts filtrate.With the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
The traditional Chinese medical science thinks that primary disease character has the branch of deficiency and excess, and the case of a physically strong patient running a high fever is the high Sheng of gas fire, bleeding due to blood-heat; Deficient syndrome has for the moon hinders deficiency-fire stirring up at two: one, the blood network of burning, and one can not take the photograph blood for the deficiency of vital energy, and in a word, disorderly contrary because of the gas fire, blood can not follow through causing the network blood trouble and overflow, and the cause of disease is with being invaded by exogenous pathogen, intemperance of taking food, the congestion retardance, the prolonged illness Qi and blood deficiency is main.
Prescription of the present invention is primarily aimed at early stage heat in blood stasis type purpura, focuses on heat-clearing and toxic substances removing, dissolving stasis and dispelling spots, cooling blood for hemostasis; All medicine reasonable compatibilities in the side, complementary collaborative, dialectical treatment has better curative effect to anaphylactoid purpura.
Be the actual efficacy of checking medicine of the present invention, use medicine of the present invention and cooperate clinical treatment anaphylactoid purpura patient 80 examples.
Statistical result showed: cure 56 examples, cure rate is 70%, 21 examples that are clearly better, and total effective rate 96.3%, clinical test results prove that curative effect of medication of the present invention is definite, and has no side effect, clinical practice is safe and reliable.
The specific embodiment
Prepare raw material according to following weight:
Fructus Forsythiae 1.5kg, Radix Arnebiae (Radix Lithospermi) 1kg, Radix Salviae Miltiorrhizae 1.2kg, Radix Rehmanniae 1.2kg, Cortex Moutan 1kg, Fructus Gardeniae Preparatus 1kg, Radix Paeoniae Rubra 1kg, Rhizoma Imperatae 3.5kg, Herba Ecliptae 2.2kg, Semen Persicae 0.9kg, Radix Et Rhizoma Rhei 0.7kg, Radix Notoginseng 0.2kg.
Get the raw material mix homogeneously of above-mentioned mass fraction, add the water of 3 times of doses, water decocts after 30 minutes and extracts filtrate.With the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
Claims (4)
1. medicine for the treatment of anaphylactoid purpura is characterized in that described medicine is the medicament of being made by following materials based on weight:
Fructus Forsythiae 10-20 part, Radix Arnebiae (Radix Lithospermi) 7-14 part, Radix Salviae Miltiorrhizae 8-15 part, 12 parts in the Radix Rehmanniae, 10 parts of Cortex Moutans, Fructus Gardeniae Preparatus 7-14 part, Radix Paeoniae Rubra 7-14 part, Rhizoma Imperatae 30-40 part, Herba Ecliptae 15-30 part, Semen Persicae 8-15 part, Radix Et Rhizoma Rhei 6-10 part, Radix Notoginseng 1-3 part.
2. the medicine of treatment anaphylactoid purpura according to claim 1 is characterized in that described medicine is the medicament of being made by following materials based on weight:
Fructus Forsythiae 10-20 part, Radix Arnebiae (Radix Lithospermi) 7-14 part, Radix Salviae Miltiorrhizae 8-15 part, 12 parts in the Radix Rehmanniae, 10 parts of Cortex Moutans, Fructus Gardeniae Preparatus 7-14 part, Radix Paeoniae Rubra 7-14 part, Rhizoma Imperatae 30-40 part, Herba Ecliptae 15-30 part, Semen Persicae 8-15 part, Radix Et Rhizoma Rhei 6-10 part, Radix Notoginseng 1-3 part.
3. the medicine of treatment anaphylactoid purpura according to claim 1 and 2 is characterized in that described medicament is an oral liquid.
4. the preparation method of treatment allergy purpura according to claim 3, it is characterized in that the raw material of getting above-mentioned parts by weight mixes, the water that adds 2-4 times of dose, water decocts after 20-40 minute and extracts filtrate, with the method decocting 3 times, get three filtrates and mix, sterilization, oral liquid is made in packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010505907 CN101979057A (en) | 2010-10-10 | 2010-10-10 | Medicine for treating anaphylactoid purpura and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010505907 CN101979057A (en) | 2010-10-10 | 2010-10-10 | Medicine for treating anaphylactoid purpura and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101979057A true CN101979057A (en) | 2011-02-23 |
Family
ID=43599612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010505907 Pending CN101979057A (en) | 2010-10-10 | 2010-10-10 | Medicine for treating anaphylactoid purpura and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101979057A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688917A (en) * | 2015-03-28 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for curing anaphylactoid purpura |
| CN105125876A (en) * | 2015-10-12 | 2015-12-09 | 青岛恒波仪器有限公司 | Chinese herbal preparation for treating children anaphylactoid purpura and preparing method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015607A (en) * | 2006-12-27 | 2007-08-15 | 辽宁中医药大学 | Traditional Chinese medicine for treating immune thrombocytopenic purpura and preparing method thereof |
| CN101574467A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine preparation for curing purpura |
| CN101584773A (en) * | 2009-06-10 | 2009-11-25 | 张学贵 | Chinese herbal medicament for treating skin diseases |
-
2010
- 2010-10-10 CN CN 201010505907 patent/CN101979057A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015607A (en) * | 2006-12-27 | 2007-08-15 | 辽宁中医药大学 | Traditional Chinese medicine for treating immune thrombocytopenic purpura and preparing method thereof |
| CN101574467A (en) * | 2009-04-07 | 2009-11-11 | 北京万寿通医药科技有限公司 | Traditional Chinese medicine preparation for curing purpura |
| CN101584773A (en) * | 2009-06-10 | 2009-11-25 | 张学贵 | Chinese herbal medicament for treating skin diseases |
Non-Patent Citations (1)
| Title |
|---|
| 《河南中医》 19931231 王心好 连紫化癜汤治疗过敏性紫癜50例疗效观察 第282-283页 1-4 第13卷, 第6期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688917A (en) * | 2015-03-28 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for curing anaphylactoid purpura |
| CN105125876A (en) * | 2015-10-12 | 2015-12-09 | 青岛恒波仪器有限公司 | Chinese herbal preparation for treating children anaphylactoid purpura and preparing method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN103830535B (en) | Pharmaceutical composition for the treatment of rhinitis and its production and use | |
| CN103393966A (en) | Chinese medicinal composition for treating irregular menstruation | |
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN101979057A (en) | Medicine for treating anaphylactoid purpura and preparation method thereof | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN104623376A (en) | Medicament for treating prosopalgia | |
| CN102614479B (en) | Traditional Chinese medicine lotion preparation method for curing kidney-yang deficiency ecthyma | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN105617036A (en) | Traditional Chinese medicine preparation for treating cardiovascular disease and production method thereof | |
| CN104069421A (en) | Traditional Chinese medicine composition for treating heart diseases | |
| CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
| CN104623333A (en) | Drug for treating facial paralysis | |
| CN103432358B (en) | Medicament for treating psoriasis | |
| CN106309636B (en) | Pharmaceutical composition for uterine bleeding | |
| CN103990101A (en) | Traditional Chinese medicine composition for treating gynecological disease | |
| CN105288452A (en) | Preparation method of medicine for treating jaundice | |
| CN103736011A (en) | Injection nursing medicine for lowering cholesterol and preparation method thereof | |
| CN104721450A (en) | Traditional Chinese medicine for treating abnormal menstruation and preparation method thereof | |
| CN104510827A (en) | Traditional Chinese medicine for treating acne | |
| CN103816309A (en) | Traditional Chinese medicine for treating tinnitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20110223 |